ATE176402T1 - Serinprotease enthaltender impfstoff - Google Patents

Serinprotease enthaltender impfstoff

Info

Publication number
ATE176402T1
ATE176402T1 AT94917738T AT94917738T ATE176402T1 AT E176402 T1 ATE176402 T1 AT E176402T1 AT 94917738 T AT94917738 T AT 94917738T AT 94917738 T AT94917738 T AT 94917738T AT E176402 T1 ATE176402 T1 AT E176402T1
Authority
AT
Austria
Prior art keywords
pct
serine protease
vaccine containing
containing serine
sec
Prior art date
Application number
AT94917738T
Other languages
English (en)
Inventor
John Pius Dalton
Stuart John Andrews
Original Assignee
John Pius Dalton
Stuart John Andrews
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Pius Dalton, Stuart John Andrews filed Critical John Pius Dalton
Application granted granted Critical
Publication of ATE176402T1 publication Critical patent/ATE176402T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT94917738T 1993-06-15 1994-06-14 Serinprotease enthaltender impfstoff ATE176402T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939312324A GB9312324D0 (en) 1993-06-15 1993-06-15 Vaccine

Publications (1)

Publication Number Publication Date
ATE176402T1 true ATE176402T1 (de) 1999-02-15

Family

ID=10737190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94917738T ATE176402T1 (de) 1993-06-15 1994-06-14 Serinprotease enthaltender impfstoff

Country Status (14)

Country Link
US (1) US5885814A (de)
EP (1) EP0703789B1 (de)
JP (1) JPH08511262A (de)
AT (1) ATE176402T1 (de)
AU (1) AU694121B2 (de)
DE (1) DE69416405T2 (de)
DK (1) DK0703789T3 (de)
ES (1) ES2130426T3 (de)
GB (1) GB9312324D0 (de)
GR (1) GR3030116T3 (de)
HU (1) HUT71209A (de)
NZ (1) NZ267139A (de)
WO (1) WO1994028925A1 (de)
ZA (1) ZA944241B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
AUPO767497A0 (en) * 1997-07-04 1997-07-24 Australian Wool Research & Promotion Organisation Parasite vaccine
US20030065382A1 (en) * 2001-10-02 2003-04-03 Fischell Robert E. Means and method for the treatment of coronary artery obstructions
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
EP1745292A2 (de) 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnositka und therapeutika für mit dipeptidyl-peptidase 1 (dpp1) assoziierten krankheiten
WO2011043962A2 (en) 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
BR112018071583A2 (pt) * 2016-04-21 2019-02-12 Sphingotec Therapeutics Gmbh métodos para determinar dpp3 e métodos terapêuticos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001277A1 (en) * 1986-08-18 1988-02-25 The Australian National University Helminth parasite vaccine
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
NZ230773A (en) * 1988-09-26 1993-04-28 Biotech Australia Pty Ltd Nematode antigenic peptides and vaccines
CA2147378A1 (en) * 1992-10-21 1994-04-28 John P. Dalton Vaccine containing a thiol protease

Also Published As

Publication number Publication date
HUT71209A (en) 1995-11-28
GB9312324D0 (en) 1993-07-28
NZ267139A (en) 1998-01-26
DK0703789T3 (da) 1999-09-20
EP0703789A1 (de) 1996-04-03
DE69416405D1 (de) 1999-03-18
ZA944241B (en) 1995-05-26
AU694121B2 (en) 1998-07-16
US5885814A (en) 1999-03-23
HU9403591D0 (en) 1995-03-28
GR3030116T3 (en) 1999-07-30
ES2130426T3 (es) 1999-07-01
DE69416405T2 (de) 1999-09-09
JPH08511262A (ja) 1996-11-26
AU6933394A (en) 1995-01-03
EP0703789B1 (de) 1999-02-03
WO1994028925A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
ATE246681T1 (de) Sulfonamide
ES2141631T3 (es) Estabilizacion del hidrocloruro de naloxon.
ATE176593T1 (de) Transdermale wirkstoffzubereitung
DK0697019T3 (da) Risperidon pamoater
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DE69326250D1 (de) Neuropeptide y antagoniste
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
FI884955A (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
DE69332977D1 (de) Thiolprotease enthaltender impfstoff
ATE176402T1 (de) Serinprotease enthaltender impfstoff
ITMI921551A1 (it) Glutatione come agente chemioprotettivo
DK0651764T3 (da) Cytotoksisk T-lymfocytantigen som cysteinproteaseinhibitor
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
ES2105314T3 (es) Derivados de (amino-3 fenil)-1 etanosulfonato de alquilamonio opticamente activos, su preparacion y su utilizacion.
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
ES2083874T3 (es) (amino-3 fenil)-1 etanosulfonato de hidroquinina opticamente activo, su preparacion y su utilizacion.
ATE206127T1 (de) Inhibitoren retroviraler proteasen
AR001341A1 (es) Composición coadyuvante líquida de uso agricola.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee